IRIDEX Corporation, based in Mountain View, United States, is dedicated to providing advanced semiconductor-based laser systems for the treatment of eye diseases and skin lesions. The company offers a range of products including the patented Fovea-friendly™ MicroPulse® laser technology for retinal diseases, high-quality laser systems and EndoProbe® handpieces for precision surgery, and various laser solutions for glaucoma management. IRIDEX serves the ophthalmic, dermatological, and research markets globally.
IRIDEX has made significant strides in the medical field with its innovative laser technologies, enhancing treatment options for common retinal diseases and glaucoma. The company's products are widely recognized for their precision and effectiveness, contributing to improved patient outcomes worldwide. Through its commitment to quality and innovation, IRIDEX continues to impact the medical community positively by providing reliable and cutting-edge solutions for both office-based practices and operating rooms.
